Injeq visited Hong Kong as part of the Finnish HealthTech delegation. There were many interesting introductions of business opportunities in Hong Kong and in Greater Bay Area. Our CEO Timo Hänninen had a pleasure to give a presentation of the IQ-TipR system as the first digital needle solution on the market in the world class cancer treatment hospital at Hong Kong Sanatorium and Hospital Proton Therapy Centre.
Tiedote osakkeenomistajille / Notice to shareholders
TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »
News release on April 12, 2024
The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »
Information to shareholders, March 22nd, 2024
Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »
Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen
Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »
New distributor agreement with “GENFAX SRL”
We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »
Injeq webinar today, Thursday Feb 22nd, 2024
Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone) Lecturers […]
Read more »